Erythropoietin and a hypoxiaâinducible factor prolyl hydroxylase inhibitor (HIFâPHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Noonan, Megan L., Clinkenbeard, Erica L., Ni, Pu, Swallow, Elizabeth A., Tippen, Samantha P., Agoro, Rafiou, Allen, Matthew R., White, Kenneth E.Том:
8
Журнал:
Physiological Reports
DOI:
10.14814/phy2.14434
Date:
June, 2020
Файл:
PDF, 753 KB
2020
File converter
Більше результатів пошуку
More benefits 
